Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 549)
Posted On: 08/25/2023 1:22:53 PM
Post# of 155359
Posted By: ohm20
Quote:
leronlimab PLUS carboplatin, according to cytodyn, was generally comparable to trodelvy. of course the data didn't agree, but it showed some efficacy. that ws leronlimab PLUS carboplatin vs trodelvy ALONE. - truths



More half truths from you. The data for Trodelvy is from historical data Trodelvy itself contains a chemotherapy component. Why leronlimab's p values didn't blow away Trodelvy comes from a very simple fact. Trodelvy's numbers were from trials with a very large numbers of patients which of course strengthens the p value. Our trial on the other hand had a very small number of patients which weakens p values. Even with that small number of patients we beat Trodelvy,

Quote:
is all way above your heads anyway



It is for sure way above your head. Go read thousands of medical papers and then come at me with your facts instead of distortions and outright lies.













(21)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site